IGM Biosciences, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Report date

3/31/2025

Quarter

2025 Q1

Filed

5/19/2025

Shares

1,164

Value ($000)

1

Weight

0.0%

2020 Q2 - 2025 Q1 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q1	5/19/2025	1	0.0%	1,164	3/31/2025
2023 Q3	11/13/2023	93	0.0%	11,145	9/30/2023
2023 Q2	8/11/2023	6,664	0.0%	485,027	6/30/2023
2023 Q1	5/15/2023	6,664	0.0%	485,027	3/31/2023
2022 Q4	2/14/2023	8,245	0.0%	484,699	12/31/2022
2022 Q3	11/14/2022	11,923	0.0%	524,311	9/30/2022
2022 Q2	8/12/2022	9,671	0.0%	536,409	6/30/2022
2022 Q1	5/16/2022	14,988	0.0%	560,711	3/31/2022
2021 Q4	2/14/2022	10,579	0.0%	360,679	12/31/2021
2021 Q3	11/15/2021	20,778	0.0%	315,967	9/30/2021
2021 Q2	8/16/2021	27,920	0.0%	335,579	6/30/2021
2021 Q1	5/14/2021	19,321	0.0%	251,932	3/31/2021
2020 Q4	3/1/2021	26,394	0.0%	298,950	12/31/2020
2020 Q3	11/13/2020	7,796	0.0%	105,619	9/30/2020
2020 Q2	8/14/2020	5,791	0.0%	79,332	6/30/2020